Clause 5. Additional considerations for partly subsidised or unsubsidised pharmaceutical products

5

Additional considerations for partly subsidised or unsubsidised pharmaceutical products

When determining whether the cost of a partly subsidised or unsubsidised pharmaceutical product is an additional expense of a kind required by section 85(2)(d) of the Act, you must have regard to the matters in clause 4 and the following additional matters-

(a)

The availability of another subsidised or partly subsidised pharmaceutical product which may be adequate to meet the need referred to in clause 2(1)(d); and

(b)

Whether the applicant has applied to the appropriate District Health Board or other agency under the New Zealand Public Health and Disability Act 2000 for a subsidy, or an increased subsidy, on the pharmaceutical product concerned, and if so, whether that application has been accepted or declined and the reasons for it being declined (if applicable).